127 related articles for article (PubMed ID: 10993774)
21. Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium.
Strohm C; Barancik T; Brühl ML; Kilian SA; Schaper W
J Cardiovasc Pharmacol; 2000 Aug; 36(2):218-29. PubMed ID: 10942164
[TBL] [Abstract][Full Text] [Related]
22. Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels.
Zhao TC; Hines DS; Kukreja RC
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1278-85. PubMed ID: 11179074
[TBL] [Abstract][Full Text] [Related]
23. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs.
Vahlhaus C; Schulz R; Post H; Rose J; Heusch G
J Mol Cell Cardiol; 1998 Feb; 30(2):197-209. PubMed ID: 9514996
[TBL] [Abstract][Full Text] [Related]
24. Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways.
Skyschally A; Gent S; Amanakis G; Schulte C; Kleinbongard P; Heusch G
Circ Res; 2015 Jul; 117(3):279-88. PubMed ID: 26058828
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
Das S; Tosaki A; Bagchi D; Maulik N; Das DK
J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
[TBL] [Abstract][Full Text] [Related]
26. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo.
Schulz R; Gres P; Skyschally A; Duschin A; Belosjorow S; Konietzka I; Heusch G
FASEB J; 2003 Jul; 17(10):1355-7. PubMed ID: 12759340
[TBL] [Abstract][Full Text] [Related]
27. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation.
Tanno M; Gorog DA; Bellahcene M; Cao X; Quinlan RA; Marber MS
J Mol Cell Cardiol; 2003 Dec; 35(12):1523-7. PubMed ID: 14654378
[TBL] [Abstract][Full Text] [Related]
29. lschemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3.
Gent S; Skyschally A; Kleinbongard P; Heusch G
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H478-H484. PubMed ID: 28039203
[TBL] [Abstract][Full Text] [Related]
30. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
31. Differential activation of mitogen-activated protein kinases in ischemic and nitroglycerin-induced preconditioning.
Iliodromitis EK; Gaitanaki C; Lazou A; Aggeli IK; Gizas V; Bofilis E; Zoga A; Beis I; Kremastinos DT
Basic Res Cardiol; 2006 Jul; 101(4):327-35. PubMed ID: 16612556
[TBL] [Abstract][Full Text] [Related]
32. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts.
Nakano A; Cohen MV; Critz S; Downey JM
Basic Res Cardiol; 2000 Dec; 95(6):466-71. PubMed ID: 11192367
[TBL] [Abstract][Full Text] [Related]
33. Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart.
Pantos C; Malliopoulou V; Paizis I; Moraitis P; Mourouzis I; Tzeis S; Karamanoli E; Cokkinos DD; Carageorgiou H; Varonos D; Cokkinos DV
Mol Cell Biochem; 2003 Jan; 242(1-2):173-80. PubMed ID: 12619880
[TBL] [Abstract][Full Text] [Related]
34. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
[TBL] [Abstract][Full Text] [Related]
35. Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases.
Weber NC; Goletz C; Huhn R; Grueber Y; Preckel B; Schlack W; Ebel D
Eur J Pharmacol; 2008 Sep; 592(1-3):48-54. PubMed ID: 18655783
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinase after transient forebrain ischemia in mice.
Takagi Y; Nozaki K; Sugino T; Hattori I; Hashimoto N
Neurosci Lett; 2000 Nov; 294(2):117-20. PubMed ID: 11058801
[TBL] [Abstract][Full Text] [Related]
37. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity.
Kaljusto ML; Stensløkken KO; Mori T; Panchenko A; Frantzen ML; Valen G; Vaage J
Eur J Cardiothorac Surg; 2008 Mar; 33(3):355-63. PubMed ID: 18221880
[TBL] [Abstract][Full Text] [Related]
38. Modification of ischemia/reperfusion induced infarct size by ischemic preconditioning in hypertrophied hearts.
Nusier M; Alqudah M; Elimban V; Dhalla NS
Can J Physiol Pharmacol; 2021 Feb; 99(2):218-223. PubMed ID: 33546576
[TBL] [Abstract][Full Text] [Related]
39. Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
Kocsis GF; Pipis J; Fekete V; Kovács-Simon A; Odendaal L; Molnár E; Giricz Z; Janáky T; van Rooyen J; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2406-9. PubMed ID: 18359895
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats.
Ferrandi C; Ballerio R; Gaillard P; Giachetti C; Carboni S; Vitte PA; Gotteland JP; Cirillo R
Br J Pharmacol; 2004 Jul; 142(6):953-60. PubMed ID: 15210584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
